D009569

3 trials

Sponsors

Kazufumi Nakamura, Ogo Takeshi, Matoba Satoaki

Conditions

Cardiogenic shock Cardiogenic shockMitral Regurgitation complicated with pulmonary hypertension mitral regurgitation, Pulmonary HypertensionPulmonary arterial hypertension (PAH), and Chronic thromboembolic pulmonary hypertension (CTEPH) PH, Nitric oxide, PAH, CTEPH, Right heart failure

Phase 2

Clinical trial of Nitric Oxide inhalation therapy in patients with severe PH

Active, not recruitingJPRN-jRCT2051220042

Ogo TakeshiPulmonary arterial hypertension (PAH), and Chronic thromboembolic pulmonary hypertension (CTEPH) PH, Nitric oxide, PAH, CTEPH, Right heart failure

Start: 2022-11-02Target: 30Updated: 2026-06-29

Phase 4

RecruitingJPRN-jRCT1061230015

Kazufumi NakamuraCardiogenic shock Cardiogenic shock

Start: 2025-03-06Target: 10Updated: 2026-06-29

Effects of inhaled NO on hemodynamics after transcatheter mitral valve repair in patients with mitral regurgitation complicated with pulmonary hypertension

RecruitingJPRN-jRCTs051230200

Matoba SatoakiMitral Regurgitation complicated with pulmonary hypertension mitral regurgitation, Pulmonary Hypertension

Start: 2024-03-12Target: 40Updated: 2026-06-29

Related Papers

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension　- Protocol for the PHiNO Study.

2025-02-111 citations